Neuroscience

A new clue in the mystery of ALS, frontotemporal dementia

A special focus on rogue proteins may hold future promise in stopping the progression of nerve cell destruction in people who have amyotrophic lateral sclerosis (ALS) or frontotemporal dementia.

Vaccination

Q And A: How different types of COVID-19 vaccines work

DEAR MAYO CLINIC: I know COVID-19 has been around now for over a year, but I'm still confused by the different types of vaccines, including messenger RNA and vector vaccines. Can you explain how these vaccines work and the ...

page 21 from 40